UBM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ulisse Biomed Spa

Watchlist Manager

Watchlist

Price: 0.78 EUR -2.26% Market Closed

Market Cap: €20.3m

	Ulisse Biomed Spa MIL:UBM	IT
B	BCE Inc XMUN:BCE1	CA
	Ecovyst Inc NYSE:ECVT	US
M	MacroGenics Inc SWB:M55	US

Profitability Summary

Ulisse Biomed Spa's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-87%

Negative 3Y Average Gross Margin

-728%

Gross Margin is Increasing

-1 065% > -87%

Negative Operating Margin

-571%

Negative 3Y Average Operating Margin

-2 559%

Operating Margin is Increasing

-1 843% > -571%

Negative Net Margin

-573%

Negative 3Y Average Net Margin

-2 562%

Net Margin is Increasing

-1 843% > -573%

Negative Free Cash Flow Margin

-296%

Negative 3Y Average Free Cash Flow Margin

-694%

Free Cash Flow Margin is Increasing

-1 688% > -296%

Negative ROE

-23%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-31%

ROIC is Increasing

-61% > -22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.